These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 33327238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
    Kunawudhi A, Wong AK, Alkasab TK, Mahmood U.
    Asian Pac J Cancer Prev; 2016 Oct; 17(8):4143-7. PubMed ID: 27644675
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of 18F-FDG PET/CT in the postoperative follow-up of patients with history of medullary thyroid cancer.
    Saponjski J, Macut D, Saranovic DS, Radovic B, Artiko V.
    Radiol Oncol; 2020 Nov 22; 55(1):18-25. PubMed ID: 33885241
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer.
    Kutluturk K, Simsek A, Comak A, Gonultas F, Unal B, Kekilli E.
    Niger J Clin Pract; 2019 Jan 22; 22(1):63-68. PubMed ID: 30666022
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis.
    Noij DP, Martens RM, Zwezerijnen B, Koopman T, de Bree R, Hoekstra OS, de Graaf P, Castelijns JA.
    Eur J Radiol; 2018 Oct 22; 107():20-25. PubMed ID: 30292267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A, Xue J, Hu M, Zheng J, Wang X.
    Cancer Epidemiol; 2012 Oct 22; 36(5):470-5. PubMed ID: 22504050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus 18F-FDG PET/CT for Detection of Bone Metastases.
    Sun W, Li M, Gu Y, Sun Z, Qiu Z, Zhou Y.
    AJR Am J Roentgenol; 2020 Feb 22; 214(2):446-454. PubMed ID: 31799866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS, Kumar R, Mittal BR, Sharma V, Singh H, Nada R, Bal A, Rohilla M, Singh H, Rana SS.
    Eur Radiol; 2021 Apr 22; 31(4):2199-2208. PubMed ID: 33001304
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.
    Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Acta Otolaryngol; 2019 Sep 22; 139(9):810-815. PubMed ID: 31274365
    [Abstract] [Full Text] [Related]

  • 15. Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC.
    Al-Ibraheem A, Hirmas N, Fanti S, Paez D, Abuhijla F, Al-Rimawi D, Al-Rasheed U, Abdeljalil R, Hawari F, Alrabi K, Mansour A.
    BMC Med Imaging; 2021 Mar 17; 21(1):49. PubMed ID: 33731050
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH, Jung DW, Pak KJ, Kim IJ, Kim HJ, Cho JK, Shin SC, Wang SG, Lee BJ.
    Head Neck; 2018 Jan 17; 40(1):94-102. PubMed ID: 29130586
    [Abstract] [Full Text] [Related]

  • 17. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.
    Qu YH, Long N, Ran C, Sun J.
    Clin Transl Oncol; 2021 Mar 17; 23(3):620-627. PubMed ID: 32683540
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT.
    Okuyucu K, Ince S, Alagoz E, Emer O, San H, Balkan E, Ayan A, Meric C, Haymana C, Acıkel C, Gunalp B, Karacalioglu AO, Arslan N.
    Hell J Nucl Med; 2016 Mar 17; 19(3):208-217. PubMed ID: 27824959
    [Abstract] [Full Text] [Related]

  • 19. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
    Ali SA, Amin DH, Abdelkhalek YI.
    Jpn J Radiol; 2020 May 17; 38(5):472-479. PubMed ID: 32078123
    [Abstract] [Full Text] [Related]

  • 20. The application of 18F-FDG-PET/CT in gastric cancerstaging and factors affecting its sensitivity.
    Dębiec K, Wydmański J, d'Amico A, Gorczewska I, Krzywon A, Cortez AJ, Pelak MJ.
    Hell J Nucl Med; 2021 May 17; 24(1):66-74. PubMed ID: 33866341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.